omniture

Winner Medical Reports First Quarter Fiscal 2011 Results

2011-02-10 20:30 1150
  • Revenue increased by 19.4% over Q4 FY 2010 and 13.2% over Q1 FY2010 to $33.7 million
  • Sales to North and South America increased 50.2% YOY
  • Reiterates FY 2011 revenue guidance of $138-150 million, representing 20%-30% YOY Growth

SHENZHEN, China, Feb. 10, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today reported consolidated financial results for the first quarter ended December 31, 2010.

Fiscal First Quarter 2011 Results (in millions of USD, except per share data)


 

Q1 FY2011

 

Q4 FY2010

 

% Change

 

Q1 FY2010

 

% Change

 

 

Net Sales

 

$33.7

 

$28.2

 

19.35%

 

$29.8

 

13.2%

 

 

Cost of Sales

 

$24.2

 

$19.4

 

24.74%

 

$20.4

 

19.0%

 

 

Gross Profit

 

$9.5

 

$8.8

 

7.3%

 

$9.4

 

0.5%

 

 

Gross Margin

 

28.1%

 

31.3%

 

(10.1)%

 

31.7%

 

(11.2)%

 

 

Net Income Attributable to Winner Medical Group Inc.

 

$3.3

 

$3.1

 

6.7%

 

$3.9

 

(15.1)%

 

 

EPS (Diluted)

 

$0.14

 

$0.13

 

7.7%

 

$0.17

 

(17.6)%

 

 

 

 

 

 

 

 


Mr. Jianquan Li, Chairman and Chief Executive Officer of Winner Medical, commented, "During the first quarter of fiscal year 2011, cotton prices continued to increase and these raw material price increases were shifted to our customers. Early in the quarter, some customers chose to delay purchases and reduced their inventory while monitoring cotton price trends. Starting in November, having depleted the majority of their inventory, our customers increased their purchases again, resulting in December sales being one of the strongest months that Winner Medical has recorded in recent years. I believe the medical dressings and medical disposables markets have now largely accepted the cotton price increases from last year and we expect positive margin and sales growth for the remainder of 2011."  

First Quarter 2011 Unaudited Financial Results

Winner Medical reported net sales of $33.7 million, an increase of 13.2% compared to the same period last year. The increase was mainly attributable to higher average sales prices and increased sales orders from Chinese, North American and South American customers. Export sales to North and South America remained robust, increasing 50.2% year over year, driven by increased orders from American and Brazilian clients who recognized Winner Medical's high quality products and timely delivery capabilities. Orders in Europe remained stable year-over-year as customers in Sweden increased purchases while clients in Greece and Spain postponed orders as a result of the debt crisis. Sales were up 1.0% in China, with steady improvements in November and December. Strong sales of medical dressings and disposables were offset by lower sales of protective gowns and face masks, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Cost of goods sold increased 19.0% to $24.2 million in the first quarter of fiscal 2011, from $20.4 million in the first quarter of fiscal 2010. Cost of goods sold as a percentage of net revenues were 71.9% and 68.3% for the first quarter in fiscal 2011 and 2010, respectively. This increase was mainly attributable to increased raw material prices. To minimize the impacts brought by increased cotton prices, the Company increased its selling price progressively and purchased cotton futures contracts to hedge against the volatility of cotton prices.

Gross profit increased 0.5% to $9.5 million compared to the first quarter of fiscal 2010. Gross margin decreased to 28.1% as compared to 31.7% in the first quarter of fiscal 2010. The decrease in gross margin was mainly attributable to time lag for customers to accept higher selling prices, especially in the months of October and earlier November 2010, as well as lower sales of protective gowns and face masks, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Selling, general and administrative expenses increased by 13.8% to $6.1 million in the first quarter of fiscal 2011, from $5.3 million in the first quarter of fiscal 2010. Adjusted selling, general and administrative expenses (non- GAAP), which exclude share-based compensation expenses, for the first quarter of fiscal 2011 were $5.8 million, versus $5.0 million for the same period of 2010. The increase was primarily due to increased of salary and leasing expenses compared to the same period of last year.

The income tax provision for the first quarter of fiscal 2011 was $0.4 million, compared to $0.6 million for the same period in 2010. This decrease was primarily due to a tax deduction accrued in the reporting quarter for the 150% tax deductible preferential policy applicable to Winner Medical's Research and Development expenses while such an accrual was not made in the same period last fiscal year.

Net income attributable to Winner Medical decreased by 15.1% to $3.3 million, or $0.14 per basic and diluted share, compared to net income of $3.9 million, or $0.18 per basic share and $0.17 per diluted share, for the first quarter of fiscal 2010. The weighted average diluted shares outstanding were 24.1 million, up 7.8% year-over-year. Adjusted net income attributable to Winner Medical Group Inc. (non-GAAP), which excludes non-cash share-based compensation expenses, was $3.6 million for the first quarter of fiscal 2011, a decrease of 14.54% from the same period of 2010. Excluding non-cash share-based compensation expenses, adjusted basic earnings per share (non-GAAP) was $0.15 for the three months ended December 31, 2010, versus $0.19 per share for the comparable period last year, a decrease of 20.75%. The decrease was mainly driven by our customers' delayed acceptance of increased selling prices and lower high-margin protective products sales, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Balance Sheet

Cash and cash equivalents were $10.9 million as at December 31, 2010 compared to $14.8 million as at September 30, 2010. The Company's working capital as of December 31, 2010 was $45.6 million. Total assets were approximately $132.6 million compared to $119.0 million as of September 30, 2010, while total shareholder's equity was $110.8 million and $105.9 million in the respective periods.  

First Quarter 2011 Operational Highlights

PurCotton® Business Update:

PurCotton® sales increased 78.08% during the first quarter of 2011 to $4.5 million as a result of steady wholesale sales of jumbo roll to foreign customers and robust growth of our domestic retail business, which distribution channels include chain stores, online sales and wholesales to large customers in China. Revenue generated from PurCotton jumbo rolls and retail sales were $3.6 million and $0.9 million in the first quarter of 2011, respectively.

Gross profit of Winner Medical's PurCotton retail business for the first quarter of fiscal 2011 was $0.48 million. Net loss for the retail segment was $0.5million in the first quarter of 2011 due to start up expenditures, including market research expenses, product development expenses, leasing fees, salary expenses, and expenditures relative to the Company's own B2C website development, expenses which were not incurred in the same period of fiscal 2010. PurCotton retail business losses combined with net income from the PurCotton wholesale business results in a net loss of $0.2 million for all PurCotton® product sales. We consider that the loss from PurCotton retail business was caused by the necessary cost of investment in building our retail business and our PurCotton brand.

As of February 10, 2011, the Company owns and operates 29 PurCotton chain stores in first-tier cities all over China, including four in Beijing, the capital of China, four in Shanghai and 21 stores in Guangdong province where the Company's headquarters is located. Four stores were closed because the Company eliminated those with unsatisfactory performance. During the first quarter of 2011, seven new chain stores were opened, which had limited revenue contribution but did generate start-up expenses for the three months ended December 31, 2010.

In July 2010, the Company opened its first online PurCotton® store at http://purcotton.mall.taobao.com, featuring its entire array of products on Taobao.com, the largest online trading platform in China. In September 2010, the Company also built its own B2C trading website, www.purcotton.com, which is co-branded through its retail stores. The Company will continue to leverage and expand its online platform to drive incremental sales of PurCotton® retail products.

Fiscal Year 2011 Guidance

Winner Medical reaffirms its total revenues in fiscal year 2011 to be in the range of $138 million to $150 million, representing a 20-30% year-over-year increase.

Conference Call

Winner Medical's senior management will host a conference call to discuss its first quarter fiscal year 2011 results and recent business developments.

Date of the conference call:

 

Thursday, February 10, 2011

 

 

 

 

 

Time:

 

 08:30 a.m. EST

 

 

Dial-in Number:

 

+1-800-659-1966 (US)

 

 

 

10-800-130-0399 (South China)

 

 

 

10-800-852-1490 (North China)

 

 

 

800-96-3844 (Hong Kong)

 

 

 

+1-617-614-2711 (International)

 

 

Pass code:

 

19641990

 

 

 

 


A telephone replay will be available shortly after the conclusion of the call and will be accessible through February 17, 2010 by calling +1-888-286-8010 (US) or +1-617-801-6888 (International); Pass code: 69835750.

About Winner Medical:

Winner Medical is a leading medical disposable products manufacturer in China, with business operations consisting of manufacturing, researching, developing and marketing cotton-based medical dressings and medical disposables, as well as consumer products. The Company has ten wholly-owned operating subsidiaries and three joint ventures, which manufacture tailored medical disposables and dressings, as well as non-woven fabric made from 100% natural cotton.  With a vertically integrated supply chain ranging from spinning fabric to finished goods, the Company provides its customers with a wide range of products, from surgical and wound care to consumer. The Company sells and markets its medical products and 100% natural cotton non-woven jumbo rolls in China and abroad. For nine consecutive years, the Company has been ranked as one of the top medical dressing exporters in China, with the United States, Europe, China and Japan being its most important markets. In addition, the Company distributes finished cotton non-woven consumer products under its own "PurCotton" brand name in China. With more than 20 years of international experience in the medical dressings and disposables field, the Company has a deep market understanding. This provides Winner Medical with a solid foundation, upon which it plans to expand by growing its medical grade 100% cotton retail business. To learn more about Winner Medical, please visit Winner Medical's web site at: http://ir.winnermedical.com.

Forward-Looking Statements:

This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

Non-GAAP Financial Measures

To supplement Winner Medical's consolidated financial results presented in accordance with U.S. GAAP, Winner Medical uses the following non-GAAP measures: adjusted net income attributable to Winner Medical Group Inc., adjusted earnings per share, adjusted income from operations and adjusted selling, general and administrative expenses. These measures represent net income attributable to Winner Medical Group Inc., earnings per share, income from operations and selling, general and administrative expenses, respectively, as adjusted to exclude share-based compensation expense.

Winner Medical believes that, in conjunction with GAAP financial measures, these non-GAAP measures provide meaningful supplemental information regarding its performance and liquidity and both management and investors benefit from referring to these non-GAAP measures in assessing the Company's performance and when planning and forecasting future periods. The calculation of these non-GAAP measures allows the Company to compare its operating results with those of other companies without giving effect to expenses related to share-based compensation, which may vary for different companies for reasons unrelated to the overall operating performance of a company's business.

These non-GAAP measures are not measures of performance under accounting principles generally accepted in the United States (U.S. GAAP). The Company includes them in this press release in order to:

  • improve transparency for investors;
  • assist investors in their assessment of the Company's operating performance;
  • facilitate comparisons to historical performance;
  • ensure that these measures are fully understood in light of how the Company evaluates its operating results; and
  • properly define the metrics used and confirm their calculation.

These non-GAAP measures are not meant to be considered in isolation or as a substitute for items appearing on the Company's financial statements prepared in accordance with U.S. GAAP. Rather, the non-GAAP measures should be used as a supplement to U.S. GAAP results to assist the reader in better understanding the operational performance of the Company. The Company recognizes that the usefulness of these non-GAAP measures has certain limitations, including:

  • These non-GAAP measures do not include share-based compensation expense. Because the Company periodically has granted, and expects to continue to grant, options and restricted share awards to its employees, share-based compensation expense is a necessary element of the Company's costs and ability to generate profits and cash flows. Therefore, any measure that excludes share-based compensation expense may have material limitations.
  • The manner in which the Company calculates these non-GAAP measures may differ from that of other companies, which limits their usefulness as comparative measures.

Management compensates for these limitations by using these non-GAAP measures as comparative tools, together with U.S. GAAP measurements, to assist in the evaluation of its operating performance. Please refer to the non-GAAP reconciliation tables at the end of this press release for a reconciliation of adjusted net income attributable to Winner Medical Group Inc., adjusted earnings per share, adjusted income from operations and adjusted selling, general and administrative expenses to net income attributable to Winner Medical Group Inc., earnings per share, income from operations and selling, general and administrative expenses, respectively, which are the most directly comparable U.S. GAAP financial measures.

For more information, please contact:

Company:
Ms. Huixuan Chen (Fiona)
Investor Relations Manager
Winner Medical Group Inc.
Tel:   +86-755-2806-6858
          +86-755-2813-8888 x691
Email: investors@winnermedical.com
Web:   http://ir.winnermedical.com

Investors:
Mr. Scott Powell
HC International, Inc.
Tel:   +1-917-721-9480
Email: scott.powell@hcinternational.net
Web:   http://www.hcinternational.net

 

 

 



Winner Medical Group Inc.

Consolidated Statements of Income and Comprehensive Income

 

 

 

 


 

 

Three months ended
December 31,

 

 

 

 

 

 

2010

 

2009

 

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

US$

 

US$

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

33,706,318

 

29,786,805

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

 

 

(24,225,307)

 

(20,354,958)

 

 

Gross profit

 

 

 

 

9,481,011

 

9,431,847

 

 

 

 

 

 

 

 

 

Other operating income, net

 

 

 

 

336,784

 

440,463

 

 

Exchange difference, net

 

 

 

 

(117,785)

 

(24,380)

 

 

Selling, general and administrative expenses

 

 

 

 

(6,056,065)

 

(5,323,719)

 

 

 

 

 

 

 

 

 

Income from operations

 

 

 

 

3,643,945

 

4,524,211

 

 

Interest income

 

 

 

 

34,540

 

17,872

 

 

Interest expense

 

 

 

 

(45,287)

 

(53,846)

 

 

Equity in earnings of 50 percent or less owned entities

 

 

 

 

81,285

 

(30,322)

 

 

Income before income taxes

 

 

 

 

3,714,483

 

4,457,915

 

 

 

 

 

 

 

 

 

Income taxes

 

 

 

 

(373,686)

 

(581,887)

 

 

Net income

 

 

 

 

3,340,797

 

3,876,028

 

 

 

 

 

 

 

 

 

Net loss attributable to non-controlling interests

 

 

 

 

(12,553)

 

44,684

 

 

Net income attributable to

Winner Medical Group Inc.

 

 

 

 

3,328,244

 

3,920,712

 

 

 

 

 

 

 

 

 

Comprehensive income:

 

 

 

 

 

 

 

Net income

 

 

 

 

3,340,797

 

3,876,028

 

 

Foreign currency translation difference

 

 

 

 

1,254,669

 

(172,924)

 

 

Comprehensive income attributable to

non-controlling interests

 

 

 

 

(12,988)

 

44,735

 

 

 

 

 

 

 

 

 

Comprehensive income attributable to

Winner Medical Group Inc.

 

 

 

 

4,582,478

 

3,747,839

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Winner Medical Group Inc. per share

 

 

 

 

 

 

 

- basic

 

 

 

 

0.14

 

0.18

 

 

- diluted

 

 

 

 

0.14

 

0.17

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding

 

 

 

 

 

 

 

- basic

 

 

 

 

24,116,281

 

22,363,675

 

 

- diluted

 

 

 

 

24,498,551

 

22,473,167

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Winner Medical Group Inc.

 

 

Consolidated Balance Sheets

 

 

 

 

 

 

December 31,

 

September 30,

 

 

 

 

 

 

2010

 

2010

 

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

US$

 

US$

 

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

10,896,741

 

14,818,179

 

 

Restricted bank deposits

 

 

 

 

102,738

 

285,119

 

 

Restricted broker margin account

 

 

 

 

2,837,655

 

-

 

 

Held-to-maturity investments

 

 

 

 

1,518,770

 

1,497,607

 

 

Accounts receivable, less allowances for doubtful accounts of US$194,240 and US$230,200 at December 31, 2010 and September 30, 2010, respectively

 

 

 

 

19,171,843

 

15,672,446

 

 

Amounts due from affiliated companies

 

 

 

 

2,529

 

999

 

 

Inventories

 

 

 

 

21,884,067

 

15,945,101

 

 

Prepaid expenses and other receivables

 

 

 

 

10,640,347

 

6,929,066

 

 

Income taxes recoverable

 

 

 

 

-

 

33,974

 

 

Deferred tax assets

 

 

 

 

393,421

 

428,741

 

 

Total current assets

 

 

 

 

67,448,111

 

55,611,232

 

 

Property, plant and equipment, net

 

 

 

 

60,934,103

 

60,110,367

 

 

Investment in equity investees

 

 

 

 

2,241,068

 

2,159,784

 

 

Intangible assets, net

 

 

 

 

121,760

 

125,079

 

 

Prepaid expenses and other receivables

 

 

 

 

1,373,149

 

637,748

 

 

Deferred tax assets

 

 

 

 

523,735

 

331,785

 

 

Total assets

 

 

 

 

132,641,926

 

118,975,995

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Short-term bank loans

 

 

 

 

6,009,912

 

-

 

 

Accounts payable

 

 

 

 

7,219,825

 

5,362,155

 

 

Accrued payroll and employee benefits

 

 

 

 

2,807,179

 

2,393,700

 

 

Customer deposits

 

 

 

 

881,656

 

687,275

 

 

Accrued and other liabilities

 

 

 

 

3,142,479

 

3,057,445

 

 

Amounts due to affiliated companies

 

 

 

 

50,153

 

58,338

 

 

Income taxes payable

 

 

 

 

1,713,575

 

1,477,212

 

 

Total current liabilities

 

 

 

 

21,824,779

 

13,036,125

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

43,204

 

42,699

 

 

Total liabilities

 

 

 

 

21,867,983

 

13,078,824

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

-

 

-

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

Common stock, par value $0.001 per share; authorized 247,500,000, issued and outstanding December 31, 2010  -24,130,247 shares; September 30, 2010 - 23,950,740 shares

 

 

 

 

24,131

 

23,951

 

 

Additional paid-in capital

 

 

 

 

40,435,620

 

40,154,494

 

 

Retained earnings

 

 

 

 

52,058,278

 

48,730,034

 

 

Statutory reserves

 

 

 

 

4,585,731

 

4,585,731

 

 

Accumulated other comprehensive income

 

 

 

 

13,556,996

 

12,302,762

 

 

Total Winner Medical Group Inc stockholders' equity

 

 

 

 

110,660,756

 

105,796,972

 

 

Non-controlling interests

 

 

 

 

113,187

 

100,199

 

 

Total equity

 

 

 

 

110,773,943

 

105,897,171

 

 

 

 

 

 

 

 

 

Total liabilities and equity

 

 

 

 

132,641,926

 

118,975,995

 

 

 

 

 

 

 

 



Winner Medical Group Inc.

Non-GAAP Reconciliation

 

 

 

 

December 31,

 

 

 

 

2010

 

2009

 

 

 

 

US$


 

US$


 

 

Net income attributable to Winner Medical Group Inc. (GAAP)

 

 

3,328,244

 

3,920,711

 

 

Share-based compensation

 

 

281,306

 

302,903

 

 

Adjusted net income attributable to Winner Medical Group Inc. (Non-GAAP)

 

 

3,609,550

 

4,223,614

 

 

Earnings per share (GAAP)

 

 

 

 

 

    - Basic

 

 

0.14

 

0.18

 

 

    - Diluted

 

 

0.14

 

0.17

 

 

Adjusted earnings per share (Non-GAAP)

 

 

 

 

 

    - Basic

 

 

0.15

 

0.19

 

 

    - Diluted

 

 

0.15

 

0.19

 

 

Weighted average ordinary shares outstanding

 

 

 

 

 

    - Basic

 

 

24,116,281

 

22,363,740

 

 

    - Diluted

 

 

24,498,551

 

22,473,167

 

 

 

 

 

 

 

Selling, general and administrative expenses (GAAP)

 

 

6,056,065

 

5,323,721

 

 

Share-based compensation

 

 

281,306

 

302,903

 

 

Adjusted selling, general and administrative expenses (Non-GAAP)

 

 

5,774,760

 

5,020,818

 

 

 

 

 

 
Source: Winner Medical Group Inc.
Related Stocks:
NASDAQ:WWIN
collection